HAT1 and meningioma: In addition, aptamer apHAT610 is a promising tool, superior to monoclonal antibody diagnostics, in aptahistochemistry of meningiomas overexpressing histone acetyl transferase-1 (HAT1), which are among the most aggressive meningiomas, with poor prognosis and higher rates of early relapse [135].